HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

3 hedge funds and large institutions have $3.38M invested in Hepion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TA
1
Teachers Advisors
New York
$1.6M
Vanguard Group
2
Vanguard Group
Pennsylvania
$989K
Morgan Stanley
3
Morgan Stanley
New York
$250K -$249K
PFS
4
Prospera Financial Services
Texas
$207K -$186K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$124K -$120K
Bank of Montreal
6
Bank of Montreal
Ontario, Canada
$32K -$31K
Barclays
7
Barclays
United Kingdom
$28K -$27K
Bank of New York Mellon
8
Bank of New York Mellon
New York
$27K -$30K
Cambridge Investment Research Advisors
9
Cambridge Investment Research Advisors
Iowa
$21K -$22K
Northern Trust
10
Northern Trust
Illinois
$18K -$18K
BFA
11
BlackRock Fund Advisors
California
$16K -$5K
LWM
12
LBA Wealth Management
Florida
$15K -$15K
VKH
13
Virtu KCG Holdings
New York
$14K
BIT
14
BlackRock Institutional Trust
California
$12K -$11K
BA
15
BlackRock Advisors
Delaware
$6K -$6K
Creative Planning
16
Creative Planning
Kansas
$6K
TCIM
17
TIAA CREF Investment Management
New York
$5.72K
Wells Fargo
18
Wells Fargo
California
$5K -$3K
NFG
19
Next Financial Group
Texas
$2K
Bank of America
20
Bank of America
North Carolina
$1K
Deutsche Bank
21
Deutsche Bank
Germany
$1K
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$1K -$1K
S
23
SignatureFD
Georgia
$1K -$1K
JFA
24
JNBA Financial Advisors
Minnesota
$1K
VIA
25
Vantage Investment Advisors
Pennsylvania
$1K -$1K